ctDNA

2 stories · following the connections

Health

Abbott Reports 72.2% WGS Sensitivity for Two-Year Colorectal Recurrence

By Naomi CalderOct 23, 2026, 11:58 PM UTC

Business

Exosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer Panel

By Nasdaq OMXAug 9, 2017, 1:02 PM UTC